NCT02952547View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 30, 2016

Primary Completion Date

November 26, 2016

Study Completion Date

January 10, 2017

Conditions
Healthy
Interventions
DRUG

Co-administration of DWC20155 and DWC20156

DRUG

DWJ1366 Tab.

Trial Locations (1)

Unknown

Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY